Therapeutic angiogenesis is referred to as development of new vasculature caused by various therapeutic measures such as: gene therapy, growth factors, percutaneous and transmyocardial laser revascularization. The scope of the current article is to provide review of performed clinical trials using therapeutic angiogenesis in patients with coronary artery disease.